Egalet Corp. (EGLT)

0.44
0.00 0.56
NASDAQ : Health Technology
Prev Close 0.45
Open 0.44
Day Low/High 0.44 / 0.46
52 Wk Low/High 0.42 / 2.59
Volume 178.80K
Avg Volume 614.50K
Exchange NASDAQ
Shares Outstanding 52.99M
Market Cap 24.11M
EPS -2.00
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Egalet To Co-Host Category 1 Focus Group

Egalet To Co-Host Category 1 Focus Group

--Attendees to discuss best practices in Category 1 abuse-deterrent studies--

3 Tiny Explosive Biotech Stocks for 2018

3 Tiny Explosive Biotech Stocks for 2018

Sector M&A activity is likely to pick up next year benefiting the space.

Short Interest Makes 27.3% Move For EGLT

The most recent short interest data has been released for the 05/31/2017 settlement date, which shows a 1,227,259 share increase in total short interest for Egalet Corp , to 5,725,374, an increase of 27.28% since 05/15/2017. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.

4 Undervalued Biotech Stocks

4 Undervalued Biotech Stocks

Two are turnaround stories, and two are oversold.

3 Beaten-Down Biotechs That Should Head Up

3 Beaten-Down Biotechs That Should Head Up

Synergy Pharmaceuticals, Trevena and Egalet seem to have worst-case scenarios priced into them.

Egalet Stock Sees Short Interest Decrease By 23.3%

The most recent short interest data has been released for the 05/15/2017 settlement date, which shows a 1,366,745 share decrease in total short interest for Egalet Corp , to 4,498,115, a decrease of 23.30% since 04/28/2017. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.

Oversold Conditions For Egalet (EGLT)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

2 Questions From the Biotech Mailbag

2 Questions From the Biotech Mailbag

A look at how lawsuits and FDA changes could impact the industry.

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders It Has Filed A Complaint To Recover Losses Suffered By Investors In Egalet Corporation

The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired shares of Egalet Corporation ("Egalet") (NASDAQ: EGLT) between December 15,...

Egalet Makes Friday's Biotech Mailbag

Egalet Makes Friday's Biotech Mailbag

Why the name is sagging, and what it will take to spur the sector higher.

EGLT SHAREHOLDER ALERT: The Law Offices Of Vincent Wong Reminds Investors Of A Class Action Involving Egalet Corporation And A Lead Plaintiff Deadline Of March 28, 2017

The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the Eastern District of Pennsylvania on behalf of investors who purchased Egalet Corporation (NASDAQ:EGLT) securities...

DEADLINE ALERT: Brower Piven Alerts Shareholders Of Approaching Deadline In Class Action Lawsuit And Encourages Those With Losses In Excess Of $100,000 From Investment In Egalet Corporation To Contact The Firm

The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the Eastern District of Pennsylvania on behalf...

INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders It Has Filed A Complaint To Recover Losses Suffered By Investors In Egalet Corporation

The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired shares of Egalet Corporation ("Egalet") (NASDAQ: EGLT) between December 15,...

EGLT SHAREHOLDER ALERT: The Law Offices Of Vincent Wong Reminds Investors Of Commencement Of A Class Action Involving Egalet Corporation And A Lead Plaintiff Deadline Of March 28, 2017

The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the Eastern District of Pennsylvania on behalf of investors who purchased Egalet Corporation (NASDAQ:EGLT) securities...

EGLT LOSS NOTICE: Rosen Law Firm Reminds Egalet Corporation Investors Of Important Deadline In Class Action - EGLT

Rosen Law Firm, a global investor rights law firm, reminds purchasers of Egalet Corporation securities (NASDAQ:EGLT) from December 15, 2015 through January 9, 2017, inclusive (the "Class Period") of the important March 28,...

INVESTOR ALERT: Brower Piven Encourages Shareholders Who Have Losses In Excess Of $100,000 From Investment In Egalet Corporation To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit

The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the Eastern District of Pennsylvania on behalf...

IMPORTANT INVESTOR ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit Against Egalet Corporation And Encourages Investors With Losses To Contact The Firm

Khang & Khang LLP (the "Firm") announces the filing of a class action lawsuit against Egalet Corporation ("Egalet" or the "Company") (Nasdaq: EGLT).

EQUITY ALERT: Rosen Law Firm Announces Filing Of Securities Class Action Lawsuit Against Egalet Corporation - EGLT

Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of Egalet Corporation securities (NASDAQ: EGLT) from December 15, 2015 through January 9, 2017,...

First Week of March 17th Options Trading For Egalet (EGLT)

First Week of March 17th Options Trading For Egalet (EGLT)

Investors in Egalet Corp saw new options begin trading this week, for the March 17th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the EGLT options chain for the new March 17th contracts and identified one put and one call contract of particular interest.

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces An Investigation Concerning Possible Violations Of Federal Securities Laws By Certain Officers And Directors Of Egalet Corporation

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces An Investigation Concerning Possible Violations Of Federal Securities Laws By Certain Officers And Directors Of Egalet Corporation

Levi & Korsinsky announces it has commenced an investigation of Egalet Corporation (NASDAQ:EGLT) ("Egalet") concerning possible violations of federal securities laws by the Company and/or certain of its officers and...

A Biotech Trio to Like Going Into 2017

A Biotech Trio to Like Going Into 2017

Egalet, Portola Pharmaceuticals and Amicus Therapeutics hold promise for improvement.

Biotech Hits an Inflection Point

Biotech Hits an Inflection Point

The worst appears to be over for this sector; we could see big growth ahead.

Oversold Conditions For Egalet (EGLT)

Oversold Conditions For Egalet (EGLT)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.